Pluripotent stem cells aid partial motor recovery in spinal cord injury patients

Japanese researchers at Keio University have shown promising results using iPS cells to treat severe spinal cord injuries. In their first clinical trial, four patients received implants to grow new neural cells. Two patients showed improved motor function, with one regaining the ability to stand with support. The treatment appears safe, with no adverse effects observed.

This breakthrough could significantly increase the percentage of patients who regain motor function beyond the current 10-12% achieved through rehabilitation alone. While larger trials are needed, this advancement offers hope for the estimated 100,000 people with spinal cord injuries in Japan.